Aikawa-Aikawa Laboratories

Nagy, Edit

(617) 525-4386

Dr. Nagy is a Cardiologist from the Karolinska University Hospital, Karolinska Institutet‘s Experimental Cardiovascular Research Unit, headed by Professor Göran K. Hansson, Stockholm, Sweden. Currently, Dr. Nagy works on cardiovascular and valvular calcification in Dr. Elena Aikawa’s lab.

Dissertation
Nagy E. Molecular mechanisms of inflammation and calcification in aortic valve stenosis [dissertation], Karolinska Institutet; 2012.

Publications

Labat C, Temmar M, Nagy E, Bean K, Brink C, Benetos A, Bäck M

Inflammatory mediators in saliva associated with arterial stiffness and subclinical atherosclerosis.

J Hypertens. 2013;31(11):2251-8; discussion 2258 - PMID: 23868086 - PMCID: PMC3819311 - DOI: 10.1097/HJH.0b013e328363dccc

Jensen AS, Johansson PI, Bochsen L, Idorn L, Sørensen KE, Thilén U, Nagy E, Furenäs E, Søndergaard L

Response letter to: "hypocoagulable" thromboelastography profiles in patients with cyanotic congenital heart disease: facts or technical artifacts?

Int J Cardiol. 2013;168(4):4426 - PMID: 23706329 - DOI: 10.1016/j.ijcard.2013.05.009

Nagy E, Eriksson P, Yousry M, Caidahl K, Ingelsson E, Hansson GK, Franco-Cereceda A, Bäck M

Valvular osteoclasts in calcification and aortic valve stenosis severity.

Int J Cardiol. 2013;168(3):2264-71 - PMID: 23452891 - DOI: 10.1016/j.ijcard.2013.01.207

Bäck M, Yin L, Nagy E, Ingelsson E

The leukotriene receptor antagonist montelukast and aortic stenosis.

Br J Clin Pharmacol. 2013;75(1):280-1 - PMID: 22616719 - PMCID: PMC3555071 - DOI: 10.1111/j.1365-2125.2012.04338.x

Collste O, Sörensson P, Frick M, Agewall S, Daniel M, Henareh L, Ekenbäck C, Eurenius L, Guiron C, Jernberg T, Hofman-Bang C, Malmqvist K, Nagy E, Arheden H, Tornvall P

Myocardial infarction with normal coronary arteries is common and associated with normal findings on cardiovascular magnetic resonance imaging: results from the Stockholm Myocardial Infarction with Normal Coronaries study.

J Intern Med. 2012;273(2):189-96 - PMID: 22742529 - DOI: 10.1111/j.1365-2796.2012.02567.x

Jensen AS, Johansson PI, Bochsen L, Idorn L, Sørensen KE, Thilén U, Nagy E, Furenäs E, Søndergaard L

Fibrinogen function is impaired in whole blood from patients with cyanotic congenital heart disease.

Int J Cardiol. 2012;167(5):2210-4 - PMID: 22727966 - DOI: 10.1016/j.ijcard.2012.06.019

Jensen AS, Johansson PI, Idorn L, Sørensen KE, Thilén U, Nagy E, Furenäs E, Søndergaard L

The haematocrit--an important factor causing impaired haemostasis in patients with cyanotic congenital heart disease.

Int J Cardiol. 2012;167(4):1317-21 - PMID: 22578951 - DOI: 10.1016/j.ijcard.2012.03.181

Eaton A, Nagy E, Pacault M, Fauconnier J, Bäck M

Cysteinyl leukotriene signaling through perinuclear CysLT(1) receptors on vascular smooth muscle cells transduces nuclear calcium signaling and alterations of gene expression.

J Mol Med (Berl). 2012;90(10):1223-31 - PMID: 22527886 - PMCID: PMC3438394 - DOI: 10.1007/s00109-012-0904-1

Nagy E, Bäck M

Epigenetic regulation of 5-lipoxygenase in the phenotypic plasticity of valvular interstitial cells associated with aortic valve stenosis.

FEBS Lett. 2012;586(9):1325-9 - PMID: 22616993 - DOI: 10.1016/j.febslet.2012.03.039

Nagy E, Caidahl K, Franco-Cereceda A, Bäck M

Increased transcript level of poly(ADP-ribose) polymerase (PARP-1) in human tricuspid compared with bicuspid aortic valves correlates with the stenosis severity.

Biochem Biophys Res Commun. 2012;420(3):671-5 - PMID: 22450322 - DOI: 10.1016/j.bbrc.2012.03.064

Nagy E, Andersson DC, Caidahl K, Eriksson MJ, Eriksson P, Franco-Cereceda A, Hansson GK, Bäck M

Upregulation of the 5-lipoxygenase pathway in human aortic valves correlates with severity of stenosis and leads to leukotriene-induced effects on valvular myofibroblasts.

Circulation. 2011;123(12):1316-25 - PMID: 21403093 - DOI: 10.1161/CIRCULATIONAHA.110.966846

Nagy E, Janszky I, Eriksson-Berg M, Al-Khalili F, Schenck-Gustafsson K

The effects of exercise capacity and sedentary lifestyle on haemostasis among middle-aged women with coronary heart disease.

Thromb Haemost. 2008;100(5):899-904 - PMID: 18989536 - DOI: 10.1160/th07-10-0650